BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32531934)

  • 1. Evaluation of the Impact of Cisplatin on Variances in the Expression Pattern of Leptin-Related Genes in Endometrial Cancer Cells.
    Dąbruś D; Kiełbasiński R; Grabarek BO; Boroń D
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Changes in the Expression Profile of mRNA and Proteinencoding Adiponectin in Ishikawa Cell Line under the Influence of Cisplatin - Preliminary Report.
    Kiełabsiński R; Kieszkowski P; Grabarek BO; Boroń D
    Curr Pharm Biotechnol; 2020; 21(12):1242-1248. PubMed ID: 32370713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer
    Kieszkowski P; Dąbruś D; Grabarek BO; Boroń D
    Curr Pharm Biotechnol; 2020; 21(11):1119-1128. PubMed ID: 32297576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
    J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin Changes Expression of SEMA3B in Endometrial Cancer.
    Peszek W; Kras P; Grabarek BO; Boroń D; Oplawski M
    Curr Pharm Biotechnol; 2020; 21(13):1368-1376. PubMed ID: 32410560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
    Wu X; Yan Q; Zhang Z; Du G; Wan X
    Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variances in the Expression Profile of the EMT-Related Genes in Endometrial Cancer Lines In Vitro Study.
    Nowakowski R; Grabarek B; Burnat-Olech A; Boroń D; Paul-Samojedny M
    Curr Pharm Biotechnol; 2022; 23(4):594-608. PubMed ID: 34225617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Influence of Adalimumab on the Expression Profile of Leptin-Related Genes and Proteins in Keratinocytes Treated with Lipopolysaccharide A.
    Grabarek BO; Kasela T; Adwent I; Zawidlak-Węgrzyńska B; Brus R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.
    Rouette A; Parent S; Girouard J; Leblanc V; Asselin E
    Int J Cancer; 2012 Apr; 130(8):1755-67. PubMed ID: 21618512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of ERK1/2 in leptin promoting the proliferation of human endometrial cancer cell line Ishikawa].
    Gong C; Liu Y; Xiao W; Yin J; Wang DH; Sheng H
    Ai Zheng; 2007 Nov; 26(11):1211-4. PubMed ID: 17991320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin.
    Chon HS; Marchion DC; Xiong Y; Chen N; Bicaku E; Stickles XB; Bou Zgheib N; Judson PL; Hakam A; Gonzalez-Bosquet J; Wenham RM; Apte SM; Lancaster JM
    Gynecol Oncol; 2012 Jan; 124(1):119-24. PubMed ID: 22032837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin receptor is induced in endometriosis and leptin stimulates the growth of endometriotic epithelial cells through the JAK2/STAT3 and ERK pathways.
    Oh HK; Choi YS; Yang YI; Kim JH; Leung PC; Choi JH
    Mol Hum Reprod; 2013 Mar; 19(3):160-8. PubMed ID: 23184927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells.
    Zhang X; Kyo S; Nakamura M; Mizumoto Y; Maida Y; Bono Y; Takakura M; Fujiwara H
    Cancer Lett; 2014 Apr; 345(1):106-14. PubMed ID: 24333732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.
    Fukuda T; Oda K; Wada-Hiraike O; Sone K; Inaba K; Ikeda Y; Miyasaka A; Kashiyama T; Tanikawa M; Arimoto T; Kuramoto H; Yano T; Kawana K; Osuga Y; Fujii T
    Gynecol Oncol; 2015 Jun; 137(3):538-45. PubMed ID: 25842161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
    Bae-Jump VL; Zhou C; Boggess JF; Gehrig PA
    Cancer; 2009 Sep; 115(17):3887-96. PubMed ID: 19484784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Salinomycin on Expression Pattern of Genes Associated with Apoptosis in Endometrial Cancer Cell Line.
    Kiełbasiński K; Peszek W; Grabarek BO; Boroń D; Wierzbik-Strońska M; Oplawski M
    Curr Pharm Biotechnol; 2020; 21(12):1269-1277. PubMed ID: 32400328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin stimulates interleukin-6 production via janus kinase 2/signal transducer and activator of transcription 3 in rheumatoid synovial fibroblasts.
    Muraoka S; Kusunoki N; Takahashi H; Tsuchiya K; Kawai S
    Clin Exp Rheumatol; 2013; 31(4):589-95. PubMed ID: 23622344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
    Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
    Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
    Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
    Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.